BEBT-908
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BEBT-908, covering 2023-10-11 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients [Phase 2]